Enhancing Mucosal Immunity with Cannabinoid Type 2 Ligands

Cannabinoids and Covid-19: Enhancing Mucosal Immunity with Cannabinoid Type 2 Ligands

by Craig Travis
Categories: COVID-19, Immunomodulation, Mitigate pathogenesis
We will be treating in vitro airway tissues with synthetic, non-psychoactive der...
SOUTH MIAMI, FL, United States  2
Campaign Ended!
0%
of goal
$10
Funded
Learn more here.
MedStartr Metrics on Backer(s):
2
Interest
Score
0
Pilots
0
Partners
0
Investors
0
Adoption
Score